The post These U.S. politicians dumped Tylenol maker shares before Trump’s autism warning appeared on BitcoinEthereumNews.com. A pair of United States lawmakers sold shares in Tylenol’s parent company, Kenvue (NYSE: KVUE), just days before President Donald Trump made controversial remarks linking the painkiller to autism. According to congressional financial disclosures, Senator Sheldon Whitehouse reported a full sale of his Kenvue holdings, valued between $1,001 and $15,000, on August 28, 2025.  Two days earlier, on August 26, Rep. Ro Khanna also sold Kenvue shares in the same value range.  Interestingly, Khanna had only purchased Kenvue stock on August 4, 2025, suggesting a quick reversal of position. Less than a month later, on September 22, Trump publicly urged pregnant women to avoid Tylenol, claiming that prenatal acetaminophen use could increase autism risk.  The announcement sparked backlash from health authorities and drew international condemnation, while bringing renewed attention to Kenvue, which manufactures Tylenol following its 2023 spin-off from Johnson & Johnson. Notably, the company has denied any connection, citing scientific studies showing no link.  Tylenol represents about 10% of Kenvue’s global sales and 15% of operating profits, leading analysts to note that even significant sales declines would have a limited impact on earnings. KVUE stock analysis  Meanwhile, KVUE shares have shown volatility, trading at $16.42 at the close of the last session, down more than 20% over the past month. The company’s market capitalization has also fallen by roughly $15 billion over the past two months. KVUE one-month stock price chart. Source: Finbold While there is currently no evidence that the lawmakers acted on insider information, the timing of their trades is likely to intensify scrutiny of congressional stock trading practices.  This comes amid a broader push to ban individual stock trading by members of Congress. Featured image via Shutterstock The post These U.S. politicians dumped Tylenol maker shares before Trump’s autism warning appeared first on Finbold. Source: https://finbold.com/these-u-s-politicians-dumped-tylenol-maker-shares-before-trumps-autism-warning/The post These U.S. politicians dumped Tylenol maker shares before Trump’s autism warning appeared on BitcoinEthereumNews.com. A pair of United States lawmakers sold shares in Tylenol’s parent company, Kenvue (NYSE: KVUE), just days before President Donald Trump made controversial remarks linking the painkiller to autism. According to congressional financial disclosures, Senator Sheldon Whitehouse reported a full sale of his Kenvue holdings, valued between $1,001 and $15,000, on August 28, 2025.  Two days earlier, on August 26, Rep. Ro Khanna also sold Kenvue shares in the same value range.  Interestingly, Khanna had only purchased Kenvue stock on August 4, 2025, suggesting a quick reversal of position. Less than a month later, on September 22, Trump publicly urged pregnant women to avoid Tylenol, claiming that prenatal acetaminophen use could increase autism risk.  The announcement sparked backlash from health authorities and drew international condemnation, while bringing renewed attention to Kenvue, which manufactures Tylenol following its 2023 spin-off from Johnson & Johnson. Notably, the company has denied any connection, citing scientific studies showing no link.  Tylenol represents about 10% of Kenvue’s global sales and 15% of operating profits, leading analysts to note that even significant sales declines would have a limited impact on earnings. KVUE stock analysis  Meanwhile, KVUE shares have shown volatility, trading at $16.42 at the close of the last session, down more than 20% over the past month. The company’s market capitalization has also fallen by roughly $15 billion over the past two months. KVUE one-month stock price chart. Source: Finbold While there is currently no evidence that the lawmakers acted on insider information, the timing of their trades is likely to intensify scrutiny of congressional stock trading practices.  This comes amid a broader push to ban individual stock trading by members of Congress. Featured image via Shutterstock The post These U.S. politicians dumped Tylenol maker shares before Trump’s autism warning appeared first on Finbold. Source: https://finbold.com/these-u-s-politicians-dumped-tylenol-maker-shares-before-trumps-autism-warning/

These U.S. politicians dumped Tylenol maker shares before Trump’s autism warning

A pair of United States lawmakers sold shares in Tylenol’s parent company, Kenvue (NYSE: KVUE), just days before President Donald Trump made controversial remarks linking the painkiller to autism.

According to congressional financial disclosures, Senator Sheldon Whitehouse reported a full sale of his Kenvue holdings, valued between $1,001 and $15,000, on August 28, 2025. 

Two days earlier, on August 26, Rep. Ro Khanna also sold Kenvue shares in the same value range. 

Interestingly, Khanna had only purchased Kenvue stock on August 4, 2025, suggesting a quick reversal of position.

Less than a month later, on September 22, Trump publicly urged pregnant women to avoid Tylenol, claiming that prenatal acetaminophen use could increase autism risk. 

The announcement sparked backlash from health authorities and drew international condemnation, while bringing renewed attention to Kenvue, which manufactures Tylenol following its 2023 spin-off from Johnson & Johnson.

Notably, the company has denied any connection, citing scientific studies showing no link. 

Tylenol represents about 10% of Kenvue’s global sales and 15% of operating profits, leading analysts to note that even significant sales declines would have a limited impact on earnings.

KVUE stock analysis 

Meanwhile, KVUE shares have shown volatility, trading at $16.42 at the close of the last session, down more than 20% over the past month. The company’s market capitalization has also fallen by roughly $15 billion over the past two months.

KVUE one-month stock price chart. Source: Finbold

While there is currently no evidence that the lawmakers acted on insider information, the timing of their trades is likely to intensify scrutiny of congressional stock trading practices. 

This comes amid a broader push to ban individual stock trading by members of Congress.

Featured image via Shutterstock

The post These U.S. politicians dumped Tylenol maker shares before Trump’s autism warning appeared first on Finbold.

Source: https://finbold.com/these-u-s-politicians-dumped-tylenol-maker-shares-before-trumps-autism-warning/

Market Opportunity
Union Logo
Union Price(U)
$0.002479
$0.002479$0.002479
+0.44%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

American Bitcoin’s $5B Nasdaq Debut Puts Trump-Backed Miner in Crypto Spotlight

American Bitcoin’s $5B Nasdaq Debut Puts Trump-Backed Miner in Crypto Spotlight

The post American Bitcoin’s $5B Nasdaq Debut Puts Trump-Backed Miner in Crypto Spotlight appeared on BitcoinEthereumNews.com. Key Takeaways: American Bitcoin (ABTC) surged nearly 85% on its Nasdaq debut, briefly reaching a $5B valuation. The Trump family, alongside Hut 8 Mining, controls 98% of the newly merged crypto-mining entity. Eric Trump called Bitcoin “modern-day gold,” predicting it could reach $1 million per coin. American Bitcoin, a fast-rising crypto mining firm with strong political and institutional backing, has officially entered Wall Street. After merging with Gryphon Digital Mining, the company made its Nasdaq debut under the ticker ABTC, instantly drawing global attention to both its stock performance and its bold vision for Bitcoin’s future. Read More: Trump-Backed Crypto Firm Eyes Asia for Bold Bitcoin Expansion Nasdaq Debut: An Explosive First Day ABTC’s first day of trading proved as dramatic as expected. Shares surged almost 85% at the open, touching a peak of $14 before settling at lower levels by the close. That initial spike valued the company around $5 billion, positioning it as one of 2025’s most-watched listings. At the last session, ABTC has been trading at $7.28 per share, which is a small positive 2.97% per day. Although the price has decelerated since opening highs, analysts note that the company has been off to a strong start and early investor activity is a hard-to-find feat in a newly-launched crypto mining business. According to market watchers, the listing comes at a time of new momentum in the digital asset markets. With Bitcoin trading above $110,000 this quarter, American Bitcoin’s entry comes at a time when both institutional investors and retail traders are showing heightened interest in exposure to Bitcoin-linked equities. Ownership Structure: Trump Family and Hut 8 at the Helm Its management and ownership set up has increased the visibility of the company. The Trump family and the Canadian mining giant Hut 8 Mining jointly own 98 percent…
Share
BitcoinEthereumNews2025/09/18 01:33
China Bans Nvidia’s RTX Pro 6000D Chip Amid AI Hardware Push

China Bans Nvidia’s RTX Pro 6000D Chip Amid AI Hardware Push

TLDR China instructs major firms to cancel orders for Nvidia’s RTX Pro 6000D chip. Nvidia shares drop 1.5% after China’s ban on key AI hardware. China accelerates development of domestic AI chips, reducing U.S. tech reliance. Crypto and AI sectors may seek alternatives due to limited Nvidia access in China. China has taken a bold [...] The post China Bans Nvidia’s RTX Pro 6000D Chip Amid AI Hardware Push appeared first on CoinCentral.
Share
Coincentral2025/09/18 01:09
The Japanese House of Representatives has been formally dissolved.

The Japanese House of Representatives has been formally dissolved.

PANews reported on January 23 that, according to CCTV, the Japanese Diet opened and the House of Representatives held a plenary session. Speaker Fukushiro Nukaga
Share
PANews2026/01/23 12:08